>>> Allergan shareholders signal they would accept USD 180-per-share offer from

Allergan shareholders signal they would accept USD 180-per-share offer from Valeant

The majority of Allergan’s largest investors have signalled they would support a sale of the Irvine, California-based healthcare group to NYSE-listed Valeant at USD 180 per share, a 31 May newswire report said. Bloomberg reported that an anonymous person familiar with the situation said Pershing Square Capital Management, a 9.7% Allergan shareholder which is pushing for the sale, met other Allergan shareholders on 29 May, at which time they indicated a USD 180-per-share deal would be acceptable.

The report noted that on 30 May Valeant tabled a revised offer for Allergan worth around USD 53.3bn and comprising USD 72 per share cash and 0.83 of a Valeant share - equivalent to a total USD 179.25 per share based on Valeant’s share price by end of play on 29 May, the report said. It noted that Pershing Square has offered to give up the cash part of Valeant’s offer in return for the proposal being increased for other Allergan investors.


Source Newswire Round-up, Bloomberg News

>>> Brokers Upgrades & Downgrades - 02/06/2014

>>> Up
*BARRATT DEVELOPMENTS RAISED TO BUY VS NEUTRAL AT GOLDMAN
*CONTINENTAL RAISED TO BUY VS NEUTRAL AT GOLDMAN
*DNB ASA RAISED TO OVERWEIGHT AT JPMORGAN
*ELRINGKLINGER RAISED TO NEUTRAL VS SELL AT GOLDMAN
*FORBO RAISED TO OUTPERFORM VS NEUTRAL AT CREDIT SUISSE
*GEBERIT RAISED TO EQUALWEIGHT VS UNDERWEIGHT AT MORGAN STANLEY
*KABA RAISED TO OUTPERFORM VS NEUTRAL AT CREDIT SUISSE
*LEONI RAISED TO BUY VS NEUTRAL AT GOLDMAN
*MAN GROUP RAISED TO HOLD VS SELL AT BERENBERG
*MICHELIN RAISED TO BUY VS NEUTRAL AT GOLDMAN
*PIRELLI RAISED TO NEUTRAL VS SELL AT GOLDMAN

>>> Down
*AUTONEUM CUT TO NEUTRAL VS OUTPERFORM AT CREDIT SUISSE
*BMW CUT TO NEUTRAL VS BUY AT GOLDMAN
*BNP CUT TO NEUTRAL VS CONVICTION BUY AT GOLDMAN
*ENDESA CUT TO EQUALWEIGHT VS OVERWEIGHT AT BARCLAYS
*EUROTUNNEL CUT TO HOLD VS BUY AT DEUTSCHE BANK
*GETINGE CUT TO HOLD VS BUY AT SOCGEN
*HERMES CUT TO SELL VS HOLD AT RENAISSANCE CAPITAL
*INFINEON CUT TO NEUTRAL VS BUY AT CITI
*KERING CUT TO HOLD VS BUY AT RENAISSANCE CAPITAL
*LVMH CUT TO HOLD VS BUY AT RENAISSANCE CAPITAL
*MODERN TIMES CUT TO NEUTRAL VS BUY AT SWEDBANK
*NOKIAN RENKAAT CUT TO NEUTRAL VS BUY AT GOLDMAN
*NOVATEK CUT TO NEUTRAL VS BUY AT BOFAML
*SIKA CUT TO UNDERPERFORM VS NEUTRAL AT CREDIT SUISSE
*STMICRO CUT TO SELL VS NEUTRAL AT CITI
*VESTAS CUT TO NEUTRAL VS BUY AT BOFAML
*VOLVO CUT TO SELL VS NEUTRAL AT GOLDMAN

>>> PT Changes
*ENEL PT RAISED 15% TO EU4.6 AT BARCLAYS; KEPT AT OVERWEIGHT
*Telecom Italia PT Raised to EU0.89 at Jefferies; Kept at Hold

>>> Initiation
*GAMESA REINSTATED BUY AT BOFAML, PT EU11.5
*INVESTEC RATED NEUTRAL AT GOLDMAN, PT 553P; WAS NOT RATED
*PORSCHE RATED NEUTRAL AT GOLDMAN, PT EU86; WAS NOT RATED
*VOLKSWAGEN REINSTATED NEUTRAL AT GOLDMAN, PT EU215
*WEIR GROUP RESUMED AT EQUALWEIGHT AT MORGAN STANLEY; PT 2,440P

>>> Call
>> Stock
*VODAFONE REMOVED FROM EUROPEAN RECOMMENDED PORTFOLIO AT NOMURA
>> Sector
*TECH RAISED TO OVERWEIGHT, PHARMA CUT TO NEUTRAL AT JPMORGAN

>> Autoliv not planning to split; to look at potential acquisitions

Autoliv not planning to split; to look at potential acquisitions 

Autoliv, the Swedish auto safety company, has no plans to split the company into an active safety company and a passive safety company, according to Dagens Industri. The Swedish business daily speculated that Autoliv might benefit from splitting the company in order to expose hidden value within the two business areas. The paper cited Managing Director and Chairman, Jan Carlson, who said, however, that there are no plans for a split.

Carlsson also commented that the company continues to look at potential buys and that the main criteria for an acquisition is that it suits Autoliv, not the price. The paper also asked about Autoliv’s reported earlier interest in the Israeli active safety IPO candidate, Mobileye, but Carlson declined to comment on the matter.

The item noted separately that Autoliv’s turnover for active safety for the last four quarters was SEK 2.6bn (EUR 285m).


Source Dagens Industri

>>> Asian Market Update

Asian Market Update: Australia house prices drop at fastest pace in over 5 years; China PMI hits 5-month high

***Economic Data*** - (CN) CHINA MAY MANUFACTURING PMI: 50.8 V 50.7E (3rd consecutive increase and 5-month high) - (AU) AUSTRALIA MAY RPDATA/RISMARK HOUSE PRICE INDEX: -1.9% (1st decline in a year; Biggest decline in over 5 years) V 0.3% PRIOR - (AU) AUSTRALIA APR BUILDING APPROVALS M/M: -5.6% (biggest decline in 10 months) V +2.0%E; Y/Y: 1.1% V 12.3%E - (AU) AUSTRALIA MAY AIG PERFORMANCE OF MANUFACTURING INDEX: 49.2 V 44.8 PRIOR (7th consecutive contraction, 7 months high) - (AU) AUSTRALIA Q1 COMPANY OPERATING PROFIT Q/Q: 3.1% V 2.5%E; INVENTORIES Q/Q: -1.7% V -0.4%E - (AU) AUSTRALIA MAY TD SECURITIES INFLATION M/M: 0.3% V 0.4% PRIOR; Y/Y: 2.9% V 2.8% PRIOR - (JP) JAPAN Q1 CAPITAL SPENDING Y/Y: 7.4% (7-quarter high) V 5.8%E; CAPITAL SPENDING EX-SOFTWARE Y/Y: 8.3% V 5.9%E - (JP) JAPAN MAY FINAL MARKIT/JMMA MANUFACTURING PMI: 49.9 V 49.9 PRELIM - (KR) SOUTH KOREA MAY HSBC MANUFACTURING PMI: 49.5 V 50.2 PRIOR (9-month low) - (KR) SOUTH KOREA MAY TRADE BALANCE: $5.3B v $4.5B PRIOR; 28th month of trade surplus - (VN) VIETNAM MAY HSBC MANUFACTURING PMI: 52.5 (9 straight month of expansion) V 53.1 PRIOR

Market Snapshot (as of 03:30 GMT): - Nikkei225 +1.8%, S&P/ASX +0.4%, Kospi +0.2%, Shanghai Composite closed, Hang Seng closed, Jun S&P500 +0.1% at 1,923, Aug gold +0.2% at $1,247, Jul crude oil +0.4% at $103.14/brl

***Highlights/Observations/Insights*** - China Manufacturing PMI released over the weekend beat estimates, rose for the 3rd straight month, and hit a 5-month high, but investors were hardly enthused by the marginal increase and the mixed components. Most of the increase was due to higher New Orders (52.3 v 51.2 m/m, 6-month high) and input prices (50.0 v 48.3 m/m, 5-month high). Meanwhile, new Export orders remained in contraction for the 2nd month and Employment actually fell to a 3-month low. - Also of note on the mainland, China Index Academy released its monthly housing metrics, and here the news were decisively more negative. Average price of new residential properties across 100 major cities in May fell -0.3% m/m to CNY10.98K/sqm vs +0.1% rise in April, which marked the 1st decline for the average price in 2 years. Economist with Barclays said "the risks of a disorderly adjustment are real and rising", while SocGen noted that the aggregate exposure of China's financial system to the property market is likely to be as much as 80% of GDP

- Australia released a set of economic data which were also largely negative. The housing sector down under was under the heaviest strain - building permits fell by the biggest margin in 10 months while RPDATA house price index saw its 1st decline in a year and the biggest decline in over 5 years. That should effectively keep RBA on the sidelines well into 2015 even as inflation continues to flash signs of heating up. Note today's release of TD Inflation estimate of 2.9% y/y - at the near-top end of the RBA target range. TD Securities chief economist Beacher, who was previously in the more hawkish camp, said the latest numbers led her "to push out the beginning of our expected tightening cycle from November to March 2015".

- Among notable developments in the corporate space, Nikkei reported Toyoto is planning to invest around ¥500B in domestic facilities (¥1.02T in total) in FY14/15, which would mark its post-2008 GFC high. CAPEX expansion is a good sign for Japan's top auto group, suggesting the headwind from higher consumption tax is not feeding into capacity constraints.

***Speakers/Political/In the Papers*** - (CN) China Lt Gen Wang Guanzhong (military's deputy chief of general staff): Opposed to attempts by any one nation to dominate regional security - financial press - (CN) China City of Haikou, Hainan Province (Southern China) announces measures on housing market; To ease restriction on affordable housing purchases - (VN) Chinese boat said to have damaged Vietnam coast guard ship yesterday - Vietnam press - (IN) India Fin Min Jaitley: To uphold fiscal discipline despite slowing economic growth - financial press

***Fixed Income/Commodities/Currencies*** - (JP) BOJ offers to buy ¥110B in JGBs with maturities of 1-yr and below, ¥150B in JGBs with maturity over 10-yr; *Note: BOJ offered to buy ¥170.6B in JGB with maturity over 10-yr on May 28th. - (KR) South Korea sells 3-yr Bonds; avg yield 2.840% - (KR) South Korea sells KRW961B in 30-yr government bonds at 3.575%, bid to cover 4.3x

- USD majors were little changed with the exception of AUD which sustained the most damage after the release of the soft building approvals data. AUD/USD pierced below the $0.93 handle and fell as low as $0.9260's, down over 40pips. USD/JPY tested above the ¥102 handle and Nikkei outperformed, while China indices were closed for holiday.

***Equities*** US markets: - PL: Japan's Dai-ichi Life Insurance said to be preparing to acquire life insurer Protective Life (PL) for over ¥500B - Nikkei - GOOG: Said to be in plans to invest over $1B in satellite venture to expand internet services - financial press - MTZ: Lowers Q2 guidance to $0.40 v $0.52e, Rev $1.1B v $1.15Be ($0.53, $1.15-1.20B prior)

Notable movers by sector: - Consumer Discretionary: Funtastic FUN.AU -14.5% (cuts FY14 guidance) - Financials: Dai-Ichi Mutual Life Insurance 8750.JP -4.0% (speculation of acquisition) - Materials: Kingsgate KCN.AU -1.4% (CEO to stand down due to illness) - Energy: Liquefied Natural Gas Ltd LNG.AU +8.6% (update on Magnolia LNG project); Karoon Gas Australia KAR.AU +39.4% (expects toreach Brazil partner agreement) - Industrials: Toyota Motor 7203.JP +1.2% (to invest in domestic facilities) - Technology: Panasonic 6752.JP +2.2% (speculation on Rev in Brazil)

The Telegraph China explores bond buying in first hint of QE

China explores bond buying in first hint of QE

The Chinese authorities may have to widen the range of possible options for “targeted monetary loosening”, including direct purchases of government bonds, financial and railroad debt

By Ambrose Evans-Pritchard5:20PM BST 01 Jun 2014
Officials have been clamping down on credit to puncture the property bubble but are clearly having second thoughts as money supply weakens and bad debts accumulate

China’s central bank is exploring direct purchases of bonds and other assets to support key sectors of the economy in case the slowdown deepens, according to a leading Chinese business publication.

A front-page article in the China Securities Journal – regulated by the central bank – reported growing concerns about the weakness of the money supply and bad debts accumulating in the financial system.


The authorities may have to widen the range of possible options for “targeted monetary loosening”. These include surgical stimulus for the West and Central regions, as well as “direct asset purchases by the central bank”, mostly government bonds, financial and railroad debt, as well as state-backed housing bonds.

It is the first hint of quantitative easing in China, and has left analysts scratching their heads. The central bank has many other tools available that would normally be used first to combat incipient deflation. The Reserve Requirement Ratio (RRR) is still 20pc. This could be slashed to low single-digits if need be, generating up to $2 trillion of stimulus through higher lending.

Any move in this direction would be a radical policy shift. China has been clamping down on credit deliberately over recent months in order to slow the economy and puncture the property bubble before it becomes any more dangerous, but officials have clearly been having second thoughts for several weeks. Premier Li Keqiang announced a targeted cut in the RRR on Thursday, with lower rates for banks lending to agriculture and small business.

“Chinese-style’ QE is being considered, but would only happen after a sharper economic slowdown,” said Stephen Greene and Becky Liu from Standard Chartered.

They said the central bank is looking at all options except RRR cuts, and could circumvent a ban on direct financing of government debt by using intermediate buyers. One motive would be find a new source of stimulus as the central bank slows the accumulation of foreign reserves, a policy now deemed counter-productive as holdings near $4 trillion.

Standard Chartered said it would amount to “money printing”, and would be a remarkable turn of events given Beijing’s caustic comments about the “irresponsible” monetary policy of the US Federal Reserve.

“For the Chinese to consider domestic bond purchases would be a significant move,” said George Magnus, a senior adviser to UBS. The authorities might conclude that QE packs more punch than further RRR cuts, and would be a better way to steer stimulus directly into social housing or local government finances where it is most needed without reigniting the lending boom in the wrong places.

Analysts said there may be concerns that cuts in the RRR or other conventional forms of loosening would leak out into the shadow banking system, already over a quarter of China’s $25 trillion credit edifice. The central bank is looking at surgical tools, comparable to the Bank of England’s funding for lending in some respects. “What is significant about this is that QE is not being viewed as last resort, but as a possible way of injecting controlled stimulus,” said one expert.

The authorities seem willing to tolerate to lower growth so long as it does not lead to higher unemployment. This is now a risk as the property market deflates and building projects are cancelled. Construction makes up 10pc of employment directly, and almost 20pc indirectly. It generates 39pc of the government’s total tax revenue through land sales and taxes.

Home sales dropped in China’s 27 largest cities dropped 30pc in January from a year earlier. Inventory has risen above 24 months supply in nine of these cities, according to the property group Vanke.

Zhiwei Zhang from Nomura said the authorities are already switching gears, with the central bank injecting over $30bn a month into the economy through its relending facility, a loan scheme based on collateral. Combined measures amount to a “mini-stimulus” package worth 0.8pc of GDP, led by spending on water projects, railways, and the renovation of shanty towns, though it is small beer compared to the fiscal blitz after the Lehman crisis.“It should defer the risk of a hard landing to 2015,” said Mr Zhang.

The ministry of finance said on Wednesday that it was urging local governments to boost spending and speed up payments. “The economy faces pressure, and some difficulties cannot be underestimated,” it said.

All kinds of skeletons are coming out of the cupboard as the credit bubble deflates. Caixin Magazine reported this week that the state-backed shipping group Nanjing Tanker had been forced to delist from the stock exchange after hiding “a massive amount of debt off its balance sheets”.

Soho China, one of the country’s biggest property groups, caused consternation last week by comparing the Chinese housing market to the Titanic. “After hitting the iceberg, the risks will not only be in the real estate sector. The bigger risk will be in the financial sector,” said the group’s chief executive Pan Shiyi.

The collapse will infect the shadow banking system, causing havoc for trusts and wealth products. “When housing prices fall 20pc to 30pc, these problems will be all exposed,” he said.

There is an intense debate over whether deflation risks becoming lodged into the economy. Producer prices have fallen for the last 26 months, dropping by 2pc in April. Consumer price inflation has fallen to 1.8pc, far below the central bank’s de facto target of 3.5pc.

The balance sheet of the Chinese central bank has already grown enormously since 2008, matching the QE in the US, but it has done so by accumulating foreign bonds to hold down the yuan. Purchasing bonds internally would be leap in the dark, but strange things are happening in China’s economy.

The yuan has fallen 3pc against the US dollar this year. The longer this goes on, the more the suspicion grows that China is protecting the wafer-thin margins of its export industries by allowing the exchange rate to fall.

This is leading to grumbling in Washington and Brussels that China is exporting its excess capacity – and therefore deflation – to the rest of the world. Nobody can object to quantitative easing. Everybody is playing that game now.

Barron's. Pinnacle Foods Could Be the Best Bet in a Complica

Pinnacle Foods Could Be the Best Bet in a Complicated Food Fight

The packaged-foods company looks like a bargain, even if Hillshire Brands, itself pursued by suitors, drops its bid.

A pair of meat-filled merger announcements had investors pushing aside their peas last week. But the best bargain could lie in the vegetable aisle.

Allow us to explain. Tyson Foods (ticker: TSN), which processes chicken, beef, and pork, offered Thursday to buy Hillshire Brands (HSH), the maker of Jimmy Dean breakfast sausage and Ball Park franks, for $6.1 billion, or $50 a share, in cash. The bid topped an offer made two days prior by rival Pilgrim's Pride (PPC), which sought to buy Hillshire for $45 a share.

Enlarge Image

Food fight! Tyson Foods and Pilgrim's Pride have both bid for hot-dog producer Hillshire. Both bids seem likely to spoil a third deal put on the table earlier last month, when Hillshire agreed to buy Pinnacle Foods (PF), paying $18 plus half a Hillshire share for each Pinnacle share. Pinnacle's diverse portfolio includes Birds Eye frozen vegetables, Duncan Hines cake mixes, and Wish-Bone salad dressing. Hillshire is widely expected to take the highest bidder's cash and ditch Pinnacle at the checkout counter.

Hillshire's stock jumped 44% on the week, to $53.28, while Pinnacle fell 6% to $31.31. That leaves the stock about 15% below the proposed deal price on May 23, before bidders first converged on Hillshire.

Money manager Mario Gabelli, of Gamco Investors, was right about Hillshire, twice. "It will be bought by someone," he said at last year's Barron's Roundtable, when shares sold for $29 and change ("Here's What's Cooking for 2013," Jan. 21, 2013).

In a phone call two weeks ago, after Hillshire's bid for Pinnacle, Gabelli was still hungry for takeout, saying Hillshire would be "better off being bought."

While the protein producers settle their beef, investors would be wise to turn their attention to Pinnacle. Although Hillshire's offer for Pinnacle is in danger, it gives investors a sense of what the stock could be worth to another buyer: $36 and change. Perhaps no one else will bid soon, but that could work out well for three reasons.

First, Hillshire's buyer will have to pay Pinnacle a $163 million termination fee. That's not pocket change to Parsippany, N.J.-based Pinnacle, which earned $183 million last year. Second, Pinnacle, taken public by Blackstone Group (BX) in a March 2013 initial stock offering, is succeeding with its strategy of buying well-known brands, cutting costs, and returning cash to shareholders. Even before the Hillshire bid, shares had climbed 37% to $30.45 since their first-day close. They yield 2.7%.

Third, Pinnacle looks reasonably priced. Next year's projected free cash flow of $335 million gives the stock a free-cash-flow yield of 9.1%. That compares with 4.6% for Kraft Foods Group (KRFT), 5.6% for Campbell Soup (CPB), 8% for B&G Foods (BGS), and 4.6% for Hormel (HRL). That's a good deal, whether or not there's a bull's-eye on the Birds Eye.

Barron's : Ginni Rometty: Reinventing Big Blue

Ginni Rometty: Reinventing Big Blue

Naysayers are ganging up on IBM CEO Ginni Rometty. But her plan to turn around the 103-year-old company just might work.

Ginni Rometty likes to say that there's no such thing as a bad day if you learn from it. And since taking over as chief executive of International Business Machines in January 2012, she has learned a lot. Big Blue's revenue has fallen for eight straight quarters, reaching the lowest level in five years in the first quarter of this year.

IBM (ticker: IBM) is still hugely profitable, of course, earning $18 billion last year on revenue of $100 billion. But in many ways, it faces its biggest challenge since the early 1990s, when it was on the verge of bankruptcy.

The challenge on everyone's mind is cloud computing. The problem is most tellingly illustrated by the loss last year of a major cloud-computing contract with the Central Intelligence Agency, which, like the rest of the federal government, has been an IBM customer for decades. The winner in a two-company showdown: Amazon.com (AMZN).

Another challenge is Wall Street, which has lost patience with the stock. IBM shares are down 15%, to $184, from their March 2013 high. The worry is that the company will find it increasingly hard to drive earnings higher without a surge in revenue. Rometty, a 33-year IBM veteran who holds a degree in computer science and electrical engineering, is unflappable in the face of such criticism, citing big data and analytics as the company's next big growth engine.

"We're a $100 billion ship that's going to turn," she says. "Every client I speak to -- every head of every business -- is interested in cloud, to a certain degree. But what they are really interested in is the data and analytics piece. That's going to change how they operate and what they can do."

Rometty says, "A leader's job is to paint reality and give hope." Photo: Matt Furman for Barron's Rometty, 56 years old, is nothing if not client-focused. In her first two months as CEO, she met with the heads of more than 100 IBM customers. Says David Seaton, the CEO of Fluor (FLR): "When you're with her, you feel you're the only person in the world. She has an extraordinarily high emotional-intelligence quotient. That really amplifies her ability to listen and come up with what you're asking her for."

Alex Gorsky recalls that when he took over as CEO of Johnson & Johnson (JNJ) in April 2012, Rometty knew the ins and outs of every project IBM was supporting at J&J, including diabetes care, orthopedics, big data, and computational technology. "If I gave Ginni a call right now, she would know about each one of those projects," says Gorsky.

She's also famous for showing the love -- even when a reporter shows up 30 minutes late at IBM's Armonk, N.Y., headquarters, after getting caught in a rainstorm. While other CEOs might be testy, Rometty is relaxed, gracious, and candid, despite a packed schedule that includes meetings with two client CEOs -- including the head of a large U.S. bank -- and a flight to India later that day. She has a firm handshake and a butterscotch voice.

"Catch your breath," she insists, before asking the first question of the interview: "What are people saying about IBM?" Told that cloud computing is the No. 1 concern, she asks, almost professorially, "Why do you think they say that?" Then she explains that cloud computing is just one piece of the disruption in information technology. "It's cloud, it's data, it's mobile, all at one time," she says.

ROMETTY IS THE ninth CEO in IBM's 103-year history; for the first 60 years, the company was run by founder Thomas J. Watson and his son, Thomas J. Watson Jr. Rometty is the third chief since the company's near-death experience in 1993.

Each of the CEOs in the past two decades has faced big challenges. Louis Gerstner Jr. restructured the company, slashing costs and offloading low-margin manufacturing businesses. Sam Palmisano expanded the consulting and services business dramatically, purchasing PwC Consulting for $3.5 billion in 2002, a deal championed by Rometty. He sold off the personal-computer business to escape what he called "commodity hell," and took on the very real threat of Indian outsourcing by building a massive presence in that country.

Both Gerstner and Palmisano ran headlong into criticism from Wall Street, and both were hugely successful. Now Rometty is being tested.

IBM GENERATED $4.4 billion in revenue last year from cloud computing, and Rometty expects that to climb to $7 billion in 2015. "If it was its own company, someone would think that's very large," she says acidly.

This year, the company will spend $1.2 billion to double the number of data centers for enterprise clouds, while at the same time boosting the data-security, privacy, and tracking functions that customers need for compliance and other regulatory functions.

Public cloud computing, like that offered by Amazon Web Services, allows users to rent only the computing power they need, not unlike a utility. Multiple clients share the same servers, which increases efficiency. A private cloud gains the same efficiency by sharing servers, but all are dedicated to a single client. IBM is by far the leader in private cloud computing.

"Some of the consumer guys [companies focusing on public cloud computing] brag about 99.95% availability," says Rometty. "You can't run a bank. You can't run a railroad. You can't run an airplane…that's not enough. We are used to a world of 99.99999s."

Bigger and even more promising for IBM is data and analytics, in which the company has invested about $24 billion, most notably culminating in Watson, a supercomputing system that in 2011 defeated two ranking Jeopardy champions in a $1 million exhibition match. Soon after, WellPoint (WLP) deployed Watson to help doctors and nurses make decisions on treatment options. The system can sort 200 million pages of medical research in less than three seconds, providing precise answers in plain English -- or whatever language you need -- not computerese.

Watson is being used by USAA, the Development Bank of Singapore, and V.F. Corp.'s (VFC) The North Face, among others, to sort through vast storehouses of customer data to help predict behavior and address customer needs. Watson is also helping the New York Genome Center on a trial to map the unique genomic mutations in brain cancer.

Rometty says data and analytics, including Watson Group, now a separate business unit, will generate $20 billion in revenue next year, up from $16 billion in 2013.

The third pillar of IBM's strategy is what the company calls engagement -- how clients reach their customers, employees, and other people. That includes mobile and social networking, which are the weak links in security for enterprise computing.

ROMETTY'S PERSONAL STORY shows the source of her grit and her formidable organizational skills. She grew up outside of Chicago as Virginia Nicosia, the eldest of four children in an Italian-American family. When she was in her midteens, her father left. "We had no money, we had no food," she says. "We had to go on food stamps."

Her mother got a job at a call center, and attended night school for hospital administration.

Thinking about this period, Rometty grows pensive. "She had two choices: despair, or her four kids. She was so proud. She never complained. This was not going to be permanent. She wasn't going to let people define her to be something other than a success."

From this, Rometty learned to make her own rules: "My brother says we all learned from watching [our mother]. You learn quickly to prioritize what's important. You look forward; you set a long-term course; you stay on it." All three of her siblings now have high-powered corporate jobs. They recently had a surprise party for their mother's 75th birthday.

After earning a degree from Northwestern University in 1979, Rometty went into a two-year training program at the General Motors Institute, which rotated recent college grads through various jobs at the company. That's where she met her husband, Mark Rometty, now a private-equity investor. From there, she joined IBM as a systems engineer in Detroit.

Before taking over as CEO in January 2012, she headed global sales, marketing, and strategy at IBM.

In 2007, Rometty's predecessor, Sam Palmisano, laid out what he called a "road map" to take profit from $6 a share to $11 a share through revenue growth, productivity increases, share buybacks, and fatter margins. Three years later, he upped that to $20 a share by 2015.

Analysts expect the company to earn $18.2 billion, or $17.90 a share, this year, according to FactSet, and come up 15 cents short of its target next year. Critics question the quality of IBM's earnings, which have been lifted by stock buybacks and tax maneuvers.

Rometty counters that the road map is really "a capital-allocation plan that has an outcome in earnings per share." But it's clearly a touchy subject. "We did $6.2 billion in research and development last year," she says. "We did almost $4 billion in capital expenditures. A little over $3 billion in acquisitions. About $4 billion in dividends, and a little shy of $14 billion in share repurchases. We return 100% of our net income and 100% of our free cash flow to our investors. We have a very long-term shareholder base, and they don't want us managing the company for day traders."

Her growth plan includes stabilizing hardware sales, aided by a new line of mainframe computers, and selling more open-source hardware, such as Power8 chips, which Google (GOOG) is testing in its servers. It also assumes that growth in private clouds will pick up. And with China slowing, Rometty has her eye on the next source of robust revenue gains, including Africa, where she has set up a full-fledged research lab and quadrupled IBM's presence in the past 15 months.

And yes, she says IBM will achieve its $20-a-share goal next year.

REVENUE HAS SLIPPED on Rometty's watch, from $106.9 billion in 2011 to an expected $97.4 billion this year, in part because IBM will have sold off low-margin businesses with $6 billion in revenue by the end of 2014, including its commodity-server business. Other businesses, like semiconductor manufacturing, could also go on the block.

Not coincidentally, operating profit margins have moved up in the same period, to an expected 27.5% this year from 24.9% in 2011. High-value annuity businesses, such as "mission critical" core-processing services required by banks and insurers, produce 50% of revenue and 60% of profits. And that, says Rometty, is improving every year.

For investors, however, the next year or two could be a slog. "The story is not going to work until they get the revenue growth," says Steve Milunovich of UBS. Until then, the naysayers are going to have the floor. The consensus price target for the stock on Wall Street is $194, only 5% above the current quote. The shares yield 2.4%.

Still, for all the hand-wringing over the cloud-computing business, including a price war among public cloud providers Amazon, Google, and Microsoft (MSFT), there are signs that the market may be turning IBM's way. A survey published recently by the Open Data Center Alliance, a consortium of 300 large companies, showed that interest among its members in private clouds is growing rapidly; 70% said they expect to run at least 40% of their operations on internal clouds by 2016, up from 31% today, largely due to security and regulatory concerns. Members' interest in public clouds barely budged at 20%.

"This finding suggests that IBM may be right when it says the cloud game is in the first inning," Milunovich wrote in a note to clients last week. If so, and if Rometty's transformation plan works, she could join Gerstner and Palmisano as one of the country's most-respected CEOs. 

WSJ : KKR Equities Strategies Fund Was Liquidated Last Week

KKR Equities Strategies Fund Was Liquidated Last Week 'Lack of Scale' Cited as Driving Factor in Decision to Close Firm's First Stock Hedge Fund

KKR KKR -0.22% & Co. has thrown in the towel on its first stock hedge fund.

The KKR Equities Strategies fund was liquidated last week, less than three years after it was launched, a spokeswoman confirmed. About a dozen people, including the former Goldman Sachs Group Inc. GS -0.58% traders who ran the fund, will depart the firm in the coming weeks, said a person familiar with the firm.

A KKR spokeswoman said the hedge fund's "lack of scale" was a driving factor in the decision to close it. The fund had about $500 million under management as of the start of May, about one-third of which was from KKR and its employees. The fund had fewer than 20 external investors.

Since its start in 2011, the fund reported an average annualized return of about 5%, a person with knowledge of performance said, lagging behind peers tracked by research firm HFR Inc.

The decision is the latest sign of the headwinds large financial firms face as they branch out in a bid to bring in new revenue and tap into new areas, often in search either of stronger growth or less-volatile results.

Though the hedge fund business can be lucrative, the lion's share of money flowing in in recent years has gone to established industry veterans, and startups face tough odds if they are unable to quickly post strong performance.

Bob Howard, a former executive on Goldman's proprietary trading desk who ran the KKR fund, will remain at the buyout shop in a part-time, "senior adviser" role.

Mr. Howard didn't respond to a request for comment.

WSJ : Goldman Touts Invisible Victories Over Wall Street Riv

Goldman Touts Invisible Victories Over Wall Street Rivals

If a trade falls in the forest but doesn't generate revenue, does it make a sound?

Goldman Sachs Group GS -0.58% President Gary Cohn insisted at a conference last week that his firm was expanding market share in fixed-income, currency and commodities trading. This is even though, as a portion of the aggregate trading revenue reported by big banks, Goldman's revenue has barely budged. Judged by revenue, Citigroup C +0.61% has increased its market share the most since 2011, according to a recent report from Credit Suisse Group. And the biggest gainers last quarter were Deutsche Bank DBK.XE -1.38% and Morgan Stanley. MS -0.87%

Mr. Cohn argued that since the current low-volatility environment depresses trading revenue, the normal way of gauging market share no longer works. Goldman's traders are winning more trades, he said, but "it's tough to see."

There is no direct way for investors to verify this. But it isn't implausible given the differing nature of banks' fixed-income businesses. Some have become flow monsters, focused on doing huge volumes of often lower-margin trades. Others, like Goldman, concentrate on areas that produce higher margins or would do so if volatility weren't so low.

Yet Mr. Cohn may be arguing a moot point—it is dependent on him being right that trading volumes and revenue will rise when markets "normalize." At that point, Goldman should reap the reward of a higher share of trades that produce higher margins. The risk is that rivals, even if they have given up on trades that don't make much, become far more aggressive if there is again money to be made.

In that case, today's market-share gains could end up being akin to a pig in a poke. Investors should insist on seeing what's in the bag before agreeing it is worth very much.

WSJ : A Deal for Smith & Nephew Could Face Antitrust Trauma

A Deal for Smith & Nephew Could Face Antitrust Trauma

Bid talk regarding Smith & Nephew SN.LN +1.65% is like an enduringly popular parlor game: It often isn't clear what is going on, no one ever seems to win, but everyone thoroughly enjoys playing along.

S&N, as one of the smaller makers of hip and knee implants globally, has always looked like a possible takeover target. The $13 billion agreement in April between U.S. firms Zimmer Holdings ZMH +0.47% and Biomet has reignited hopes for further consolidation.

Confirming this view, U.S. rival Stryker SYK +0.72% last week said that it had been eyeing S&N, but added it doesn't plan to bid imminently. Whether or not this eventually results in an offer, it could sharpen the thinking of U.S. antitrust regulators scrutinizing the sector.

S&N doesn't look as neat a fit as it did a few years ago. After buying ArthroCare, more than half of S&N's sales now are in sports medicine and wound care, not orthopedics. Stryker, which under U.K. rules can't make a hostile approach to S&N for six months, also has been diversifying, though in different areas. Even so, the potential cost savings in such deals, mainly from cutting orthopedic sales reps, are substantial. Zimmer reckons it can save $270 million, or 18% of Biomet's sales, general and administrative spending, by the third year.

But regulators must weigh what those big savings suggest about overlap and potential competition issues. Zimmer's confidence in its deal may be based on how regulators segment the market. Lisa Clive at Sanford C. Bernstein suggests that in the past, regulators have looked at specific product categories, distinguishing partial from total knee replacements, or primary from follow-up reconstructions.

But the headline figures may well prove alarming. A combined Zimmer and Biomet would have between 35% and 40% of the market for hip and knee replacements world-wide. If Stryker responds by buying S&N, the new firm's market share would approach 35%. With Johnson & Johnson JNJ +0.69% controlling about one-fifth, the market could quickly shift to being dominated by three players. The prospect of that could give regulators more reason to be skeptical about further tie-ups.

A Stryker-S&N deal may face another hurdle. Zimmer has little presence in the trauma market, already dominated by J&J with 50%. But a combined Stryker-S&N would have a share near 30%.

As the last orthopedic player unspoken for, shares of S&N probably deserve to a slight premium to the sector. The company is valued about 15% above U.S. peers on a price/earnings basis. But until regulators make their feelings apparent, the rules of this game remain anyone's guess.